Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
about
Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.Increased phosphatidylethanolamine N-methyltransferase gene expression in non-small-cell lung cancer tissue predicts shorter patient survival.Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanomaPPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancerDoes the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?Do PPARgamma Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis.PPAR Ligands for Cancer Chemoprevention.Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and diseaseSimulated colon fiber metabolome regulates genes involved in cell cycle, apoptosis, and energy metabolism in human colon cancer cells.Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines.
P2860
Q30414928-0534C1FB-32BB-4611-A31D-5AA454B54965Q33727484-E62BA14A-AC74-4AB5-945C-55C79E8C0E2EQ35091482-0148EF96-32F3-4DA2-9CDC-CD361EA110D4Q35458969-9BADEA49-0CEA-4B69-80A5-9EC739E8A21BQ36238973-2931807F-E9AA-43D1-9EE0-CDB3B9A1F030Q36736985-053B04C4-20FA-402A-BA1C-2107E9879CF1Q36743971-182045EC-D333-4568-B586-52E06AE61D75Q37017072-2F6B3F0C-40C0-483A-9CDF-2BA11A3286AAQ37165190-EBF42ED5-6418-47FE-AACE-A81052B514F0Q37212217-DD9A871D-8A4C-4A37-832B-61EE00602742Q38501879-11073CAE-19ED-4C57-AB7F-A7C053874BF2Q41983546-2943873B-FADC-4972-926E-25DC84AFE5A5
P2860
Concomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@ast
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@en
type
label
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@ast
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@en
prefLabel
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@ast
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@en
P2093
P2860
P356
P1433
P1476
Concomitant suppression of hyp ...... ctivity in Apc-deficient mice.
@en
P2093
Keiji Wakabayashi
Michihiro Mutoh
Naoko Niho
P2860
P304
P356
10.1515/BC.2006.051
P577
2006-04-01T00:00:00Z